CSTB and ovarian cancer: Next, we blocked the TGF-β signaling pathway by treating ovarian cancer cells with a special TGF-β type I receptor kinase inhibitor, SB-431542, to see if the regulation of CSTB expression is mediated by the TGF-β signaling pathway.